Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSR150106 in Active Rheumatoid Arthritis
NCT00545454Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of SSR150106 in rheumatoid arthritis (RA), sponsored by Sanofi. Started Oct 2007; status: completed.
02
Drugs
SSR150106
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00545454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545454.